Clinical Practice Guidelines

IEHP develops and maintains clinical practice guidelines as standards of health care applicable to members and providers. The IEHP Quality Management Committee delegates responsibility for developing, reviewing, and maintaining clinical practice guidelines to the IEHP Standards Subcommittee. The QM Committee performs final approval and adoption of all guidelines. Clinical practice guidelines requiring pharmaceutical management are initiated and investigated through the Pharmacy and Therapeutics (PT) Subcommittee prior to review by the Standards Subcommittee.

All clinical practice guidelines are based on scientific evidence, review of the medical literature, or appropriately established authority, as cited. All recommendations are based on published consensus guidelines (National Guideline Clearinghouse) and do not favor any particular treatment based solely on cost considerations.

The recommendations for care are suggested as guides for making clinical decisions. Clinicians and their patients must work together to develop individual treatment plans that are tailored to the specific needs and circumstances of each patient.

  • Attention Deficit Hyperactivity Disorder - Adults (Renewed November 2016)View »

  • Attention Deficit Hyperactivity Disorder - Pediatrics (Renewed November 2016)View »

  • Asthma Care Quick Reference - NHLBI EPR 3 (Renewed November 2016)View »

  • Behavioral Health Integration and Complex Care Initiative–Cholesterol Screening and Monitoring (New May 2017)View »

  • Behavioral Health Integration and Complex Care Initiative–Diabetes Mellitus II (New May 2017) View »

  • Behavioral Health Integration and Complex Care Initiative–Hypertension Screening and Monitoring (New May 2017) View »

  • Behavioral Health Integration and Complex Care Initiative – Major Depression (New May 2017)View »

  • Cardiovascular Health and Risk Reduction in Children and Adolescents (Renewed November 2016)View »

  • Chronic Kidney Disease (Renewed May 2016)View »

  • Chronic Kidney Disease and Diabetes (Renewed May 2017)View »

  • Chronic Obstructive Pulmonary Disease COPD (New February 2017)View »

  • Depression - Adolescent (Renewed February 2016)View »

  • Depression - Adolescent Tool Kit (Renewed February 2016)View »

  • Depression - Major Depressive Disorder (Renewed February 2016)View »

  • Diabetes Mellitus - ADA (Updated February 2017)View »

  • Diabetes Mellitus - Joslin (Renewed November 2016)View »

  • Diabetes Pregnancy (Updated February 2017)View »

  • Gastroesophageal Reflux Disease - Adults (Renewed May 2017)View »

  • Gastroesophageal Reflux Disease - Pediatrics (Updated November 2016)View »

  • Fibromyalgia (Updated November 2016)View »

  • Hepatitis C AASLD (Updated August 2016)View »

  • Hyperlipidemia - ACC/AHA (Renewed November 2015)View »

  • Hypertension (Renewed February 2016)View »

  • IVIG (Renewed May 2016)View »

  • Migraine (Renewed May 2016)View »

  • Multiple Sclerosis (Renewed November 2016)View »

  • Osteoarthritis (Renewed May 2016)View »

  • Pulmonary Arterial Hypertension (Updated May 2016)View »

  • Pain Management (Updated January 2017)View »

  • Pain Quick Reference Guide (Updated January 2017)View »

  • Psychotropic Medication Use with Children and Youth in Foster Care (Renewed May 2017)View »

  • Rheumatoid Arthritis (Updated February 2016)View »

  • Respiratory Syncytial Virus (Renewed August 2016)View »

  • Smoking Cessation (Renewed November 2016)View »

  • Sexually Transmitted Diseases - Summary of CDC Treatment Guidelines (Updated August 2016)View »

  • Synagis (Palivizumab)View »

  • Synagis FormView »